Correction to “Eosinophils and COVID-19: Insights into immune complexity and vaccine safety”

IF 4.6 2区医学 Q2 ALLERGY

Clinical and Translational Allergy Pub Date : 2025-04-14 DOI:10.1002/clt2.70056

引用次数: 0

Abstract

Sahli W, Vitte J, Desnues B. Eosinophils and COVID-19: insights into immune complexity and vaccine safety. Clin Transl Allergy. 2025;e70050.

In Figure 1, the icons of monocyte and T cell and some labels were missing. This should have appeared as the following Figure 1.

We apologize for this error.

查看原文本刊更多论文

更正“嗜酸性粒细胞与COVID-19：对免疫复杂性和疫苗安全性的见解”

王晓东，王晓东，王晓东，等。嗜酸性粒细胞与新冠肺炎：免疫复杂性和疫苗安全性的研究进展。临床变态反应。2025;e70050。在图1中，单核细胞和T细胞的图标以及部分标签缺失。这应该显示如下图1所示。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Translational Allergy Immunology and Microbiology-Immunology

CiteScore

7.50

自引率

4.50%

发文量

117

审稿时长

12 weeks

期刊介绍： Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience. Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease.